Mihály earned his MSc diploma in 2006 at Eötvös Loránd University, Budapest. After gaining practice in different cancer biology lab techniques in the National Korányi Institute of Pulmonology, he attended the Doctoral School of Pathological Sciences at Semmelweis University, under the supervision of József Tóvári (National Institute of Oncology) and Gergely Szakács (ELKH-TTK, Institute of enzymology). He defended his PhD thesis in 2020.
Currently, he is also supervisor of a PhD student at the Department of Experimental Pharmacology of the National Institute of Oncology as a postdoctoral research fellow. His main area of interest involves tumor heterogeneity, patient-derived xenograft models, tumor hypoxia & metabolism, and chemotherapy resistance in cancer. He is the principal investigator of a postdoctoral OTKA research grant (2022-2025) from National Research, Development and Innovation Office, relating acquired drug resistance in PDTX models.